The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCLL 2017 | The CLL patient: devising a management plan
Inhye Ahn, MD from the National Institutes of Health, Bethesda, MD talks about how she approaches a management plan for her chronic lymphocytic leukemia (CLL) patients. She touches on how patient lifestyle, commitment to therapy, patient co-morbidities and type of disease are major factors when deciding on treatment. This interview was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 in New York, NY
